Videos
David Pyott, former CEO, Allergan, doesn’t mince words. He explains why he took such an aggressive stance against Valeant’s bid to buy his former company.…
Read MoreAnthony P. Adamis, MD Senior Vice President and Global Head of Ophthalmology, Immunology, Infectious Disease & Metabolism, Clinical Science at Genentech, recounts the influence famous…
Read MoreAndrew Gitkin, managing director and head of West Coast biotechnology investment banking at Piper Jaffray, says ophthalmology remains one of the “top two or three”…
Read MoreJonathan Norris, a managing director for SVB’s Healthcare practice, says fund-raising numbers for biotech start-ups is strong while Medtech is seeing a decline. While VCs…
Read MoreTarek S. Hassan, M.D., Professor of Ophthalmology at Oakland University William Beaumont School of Medicine and Fellowship Director at Associated Retinal Consultants in Royal Oak,…
Read MoreNewly appointed CEO Reza Zadno, PhD, explains why he found Avedro to be such a promising opportunity. Rajesh Rajpal, MD, Chief Medical Officer, discusses two…
Read MoreJay S. Duker, MD, is the Director of the New England Eye Center (NEEC), Professor and Chairman of Ophthalmology at Tufts Medical Center and Tufts…
Read MoreNew ASRS President Mark S. Humayun, MD, PhD, shares the challenges of entrepreneurship in innovation. Co-Inventor of the world’s first FDA approved artificial retinal prosthesis…
Read MoreTracy Saxton, investment director at Roche Venture Fund, began her career at the research bench but quickly founder he way into the corporate side working…
Read MoreAdnan Butt, senior biotechnology analyst at RBC Capital Markets, says interest in ophthalmology is on the rise for products targeting both the posterior and anterior…
Read MoreNancy Lurker explains why she took over as CEO and president at pSivida and gives details on the company’s “outstanding” results of early clinical testing…
Read MoreBarry Cheskin, co-founder, president, and CEO of PowerVision Inc., delivers an update on the company’s next iteration of IOL, Fluidvision 2020. Cheskin tells OIS-TV the…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.